---
schema_version: "secwatch.filing_event.v1"
accession: "0001157523-23-000729"
form_type: "8-K"
ticker: "USNA"
cik: "0000896264"
company_name: "USANA HEALTH SCIENCES INC"
filed_at: "2023-05-04T23:59:59+00:00"
generated_at: "2026-06-15T23:49:30.345636+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# USANA Health Sciences to enter India in Q3 2023, first new market in 5 years

## Summary
- Expansion into India expected near end of Q3 2023; first new market in five years.
- India launch increases USANA's global footprint to 25 markets.
- FY2023 net sales and diluted EPS guidance (issued April 25) already reflects India's modest contribution.
- President Jim Brown cites extensive research and preparation for the launch.

## SEC filing metadata
- accession: 0001157523-23-000729
- form_type: 8-K
- ticker: USNA
- cik: 0000896264
- company_name: USANA HEALTH SCIENCES INC
- filed_at: 2023-05-04T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/896264/000115752323000729/0001157523-23-000729-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/896264/000115752323000729/a53393393.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001157523-23-000729
- JSON: https://secwatch.observer/filing/0001157523-23-000729.json
- Plain text: https://secwatch.observer/filing/0001157523-23-000729.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.